IN APPLICABILITY OF THE CARDIOVASCULAR RISK PREDICTOR "SCORE" TO PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA (FH)

IN APPLICABILITY OF THE CARDIOVASCULAR RISK PREDICTOR "SCORE" TO PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA (FH)

Bibliographic Details
Main Authors:	Descamps, O, Cooper, J, Neil, A, Humphries, S, Committee, S
Format:	Conference item
Published:	2010

Similar Items

The Genetic Spectrum of Familial Hypercholesterolemia (FH) in the Iranian Population
by: R. H. Fairoozy, et al.
Published: (2017-12-01)

Prevalence of Diabetes and Its Association with Atherosclerotic Cardiovascular Disease Risk in Patients with Familial Hypercholesterolemia: An Analysis from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH)
by: Chrysoula Boutari, et al.
Published: (2022-12-01)

Homozygous familial hypercholesterolemia (HoFH) in Germany: an epidemiological survey
by: Walzer S, et al.
Published: (2013-05-01)

NOVEL INFLAMMATORY RISK MARKERS INCLUDING LPPLA2 AND RISK OF CHD IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH)
by: Seed, M, et al.
Published: (2009)

NOVEL INFLAMMATORY RISK MARKERS INCLUDING LPPLA2 AND RISK OF CHD IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH)
by: Seed, M, et al.
Published: (2009)

FH ALERT: efficacy of a novel approach to identify patients with familial hypercholesterolemia
by: Felix Fath, et al.
Published: (2021-10-01)

Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH Protocol
by: Laney K. Jones, et al.
Published: (2022-04-01)

Correlation of cardiovascular risk predictors with overweight and obesity in patients with familial hypercholesterolemia
by: Yaodong Wang, et al.
Published: (2022-11-01)

A qualitative study of patients' perceptions of the value of molecular diagnosis for Familial Hypercholesterolemia (FH)
by: Hallowell, N, et al.
Published: (2016)

Current Status of Familial Hypercholesterolemia in China: A Need for Patient FH Registry Systems
by: Peipei Chen, et al.
Published: (2019-03-01)

Familial Hypercholesterolemia in the Elderly: An Analysis of Clinical Profile and Atherosclerotic Cardiovascular Disease Burden from the Hellas-FH Registry
by: Christina Antza, et al.
Published: (2024-01-01)

Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH Registry.
by: Khalid F Alhabib, et al.
Published: (2021-01-01)

Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry
by: Marina Cuchel, et al.
Published: (2023-05-01)

A tailored lifestyle intervention to reduce the cardiovascular disease risk of individuals with Familial Hypercholesterolemia (FH): design of the PRO-FIT randomised controlled trial
by: Brug Johannes, et al.
Published: (2010-02-01)

Facilitating family communication of familial hypercholesterolemia genetic risk: Assessing engagement with innovative chatbot technology from the IMPACT-FH study
by: Nicole L. Walters, et al.
Published: (2023-12-01)

Polygenic risk score for hypercholesterolemia in a Brazilian familial hypercholesterolemia cohort
by: Isabella Ramos Lima, et al.
Published: (2022-08-01)

The Prevalence of Heterozygous Familial Hypercholesterolemia in Selected Regions of the Russian Federation: The FH-ESSE-RF Study
by: Alexey N. Meshkov, et al.
Published: (2021-05-01)

Correction to: Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights from the CASCADE FH Registry
Published: (2023-06-01)

Web-Based Tool (FH Family Share) to Increase Uptake of Cascade Testing for Familial Hypercholesterolemia: Development and Evaluation
by: Hana Bangash, et al.
Published: (2022-02-01)

Rationale and design of the Greek registry for familial hypercholesterolemia (GRegistry-FH) of the hellenic college of treatment of atherosclerosis (HCTA)
by: Genovefa Kolovou, et al.
Published: (2020-07-01)

Risk of fatal stroke in patients with treated familial hypercholesterolemia: a prospective registry study.
by: Huxley, R, et al.
Published: (2003)

Genetic Testing and Risk Scores: Impact on Familial Hypercholesterolemia
by: Ashish Sarraju, et al.
Published: (2019-01-01)

Low Detection Rates of Genetic FH in Cohort of Patients With Severe Hypercholesterolemia in the United Arabic Emirates
by: Antoine Rimbert, et al.
Published: (2022-01-01)

How many homozygous Familial Hypercholesterolaemia (FH) patients are there likely to be in the UK? : The FH phenotype caused by the APOB p.(Arg3527Trp) variant in a South Asian family
by: I. Tracey, et al.
Published: (2022-10-01)

Achieving low-density lipoprotein cholesterol targets as assessed by different methods in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH registry
by: Christos V. Rizos, et al.
Published: (2020-05-01)

Developing and applying clinically useful approaches to identify individuals with familial hypercholesterolemia in the UK
by: Humphries, SE, et al.
Published: (2010)

Characterization of mutations in the low density lipoprotein (LDL)-receptor gene in patients with homozygous familial hypercholesterolemia, and frequency of these mutations in FH patients in the United Kingdom
by: J C Webb, et al.
Published: (1996-02-01)

Update on Familial Hypercholesterolemia: Diagnosis, Cardiovascular Risk, and Novel Therapeutics
by: Sang-Hak Lee
Published: (2017-01-01)

CURRENT STATIN TREATMENT OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH): RESULTS FROM THE ROYAL COLLEGE OF PHYSICIANS UK NATIONAL AUDIT
by: Seed, M, et al.
Published: (2011)

LIPOPROTEIN(A) MEANING AS AN ADDITIONAL MARKER OF CARDIOVASCULAR RISK IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
by: V. A. Korneva, et al.
Published: (2016-06-01)

The Prevalence of Familial Hypercholesterolemia (FH) in Chinese Patients With Acute Myocardial Infarction (AMI): Data From Chinese Acute Myocardial Infarction (CAMI) Registry
by: Hui-Wei Shi, et al.
Published: (2020-07-01)

Cardiovascular disease morbidity is associated with social deprivation in subjects with familial hypercholesterolaemia (FH): a study comparing FH individuals in UK primary care and the UK Simon Broome register linked with secondary care records
by: B. Iyen, et al.
Published: (2022-10-01)

Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH Study
by: Laney K. Jones, et al.
Published: (2021-06-01)

Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey
by: Laura D’Erasmo, et al.
Published: (2021-09-01)

Corrigendum: The Prevalence of Familial Hypercholesterolemia (FH) in Chinese Patients With Acute Myocardial Infarction (AMI): Data From Chinese Acute Myocardial Infarction (CAMI) Registry
by: Hui-Wei Shi, et al.
Published: (2020-08-01)

Spectrum of cardiovascular manifestations in homozygous familial hypercholesterolemia
by: Nitin Bajaj, et al.
Published: (2023-01-01)

Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE)
by: Isabella Sudano, et al.
Published: (2022-07-01)

Elevated lipoprotein(a) levels in Familial Hypercholesterolaemia (FH): prevalence and implications for FH clinical diagnosis
by: A. David, et al.
Published: (2023-12-01)

THE IMPORTANCE OF LIPOPROTEIN (A) TESTING WITH CASCADE SCREENING FOR FAMILIAL HYPERCHOLESTEROLEMIA (FH) IN YOUNG ADULTS WITH STATIN-RESISTANT HYPERLIPIDEMIA AT RISK FOR EARLY MAJOR ADVERSE CARDIAC EVENTS (MACE)
by: Jamal A Anthony, et al.
Published: (2023-03-01)

Risk Stratification in Familial Hypercholesterolemia
by: Jian-Jun Li, MD, PhD
Published: (2021-09-01)